FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111198130> ?p ?o ?g. }

• W2111198130 endingPage "7" @default.
• W2111198130 startingPage "1401" @default.
• W2111198130 abstract "To determine the effect of three types of interaction between physicians and the pharmaceutical industry--company-funded clinical trials, company-sponsored continuing medical education (CME) and information for physicians supplied by pharmaceutical detailers--on orientation and quality of clinical trials, content of CME courses and physicians' prescribing behaviour.MEDLINE and HEALTH searches for English-language articles published from 1978 to 1993, supplemented by material from the author's personal collection.A total of 227 papers from the MEDLINE and HEALTH searches and about 2000 items from the author's library were initially reviewed. The following selection criteria were used: studies conducted in Australia, Canada, New Zealand, Britain and the United States; studies conducted after 1977; quantitative surveys containing details of the survey methods; studies on the orientation and quality of company-funded clinical trials and on the content of CME courses giving explicit criteria used in the evaluation; and reports on the outcome of interactions stating how the outcomes were assessed. Thirty-six studies met these criteria.Information was extracted on five topics: physicians' attitudes toward drug industry interactions, frequency with which physicians participate in the interactions, orientation and quality of company-funded clinical trials, content of company-sponsored CME courses and changes in physicians' prescribing behaviour as a result of an interaction.Although most physicians participate only occasionally in company-sponsored clinical trials, most see detailers and attend company-sponsored CME courses. However, physicians do not have a very high opinion of the information from detailers or of company-sponsored CME events. Many doctors regard pharmaceutical companies as an important source of funding for clinical trials, but they also have concerns about accepting money from this source. Company funding of clinical trials may affect the quality of the trials and the types of research that physicians undertake. Company-sponsored CME courses may have a commercial bias even if conducted under guidelines designed to ensure the independence of the event. All three types of interactions affect physicians' prescribing behaviour and, in the case of obtaining information from detailers, physicians' prescribing practices are less appropriate as a result of the interaction.Physicians are affected by their interactions with the pharmaceutical industry. Further research needs to be done in most cases to determine whether such interactions lead to more or less appropriate prescribing practices. The CMA's guidelines on this topic should be evaluated to see whether they are effective in controlling physician-industry interactions. Further measures may be necessary if the guidelines fail to prevent negative effects on prescribing practices." @default.
• W2111198130 created "2016-06-24" @default.
• W2111198130 creator A5005763501 @default.
• W2111198130 date "1993-11-15" @default.
• W2111198130 modified "2023-09-30" @default.
• W2111198130 title "Interactions between physicians and the pharmaceutical industry: what does the literature say?" @default.
• W2111198130 cites W1565546494 @default.
• W2111198130 cites W1592803151 @default.
• W2111198130 cites W1634787338 @default.
• W2111198130 cites W1926663451 @default.
• W2111198130 cites W1944033505 @default.
• W2111198130 cites W1953509831 @default.
• W2111198130 cites W1956646377 @default.
• W2111198130 cites W1965109270 @default.
• W2111198130 cites W1967321179 @default.
• W2111198130 cites W1970693132 @default.
• W2111198130 cites W1973264211 @default.
• W2111198130 cites W1978417808 @default.
• W2111198130 cites W1984327217 @default.
• W2111198130 cites W1990430318 @default.
• W2111198130 cites W2006072675 @default.
• W2111198130 cites W2032610509 @default.
• W2111198130 cites W2053664176 @default.
• W2111198130 cites W2057040324 @default.
• W2111198130 cites W2074234582 @default.
• W2111198130 cites W2078122706 @default.
• W2111198130 cites W2083437552 @default.
• W2111198130 cites W2094738403 @default.
• W2111198130 cites W2117410631 @default.
• W2111198130 cites W2231689941 @default.
• W2111198130 cites W2312807852 @default.
• W2111198130 cites W2400397199 @default.
• W2111198130 cites W2412794547 @default.
• W2111198130 cites W2413526942 @default.
• W2111198130 cites W2418021618 @default.
• W2111198130 cites W2945148675 @default.
• W2111198130 cites W3026685859 @default.
• W2111198130 cites W4250032043 @default.
• W2111198130 cites W4291908614 @default.
• W2111198130 cites W2339867809 @default.
• W2111198130 cites W2411610678 @default.
• W2111198130 cites W4290126639 @default.
• W2111198130 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1485922" @default.
• W2111198130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8221424" @default.
• W2111198130 hasPublicationYear "1993" @default.
• W2111198130 type Work @default.
• W2111198130 sameAs 2111198130 @default.
• W2111198130 citedByCount "133" @default.
• W2111198130 countsByYear W21111981302012 @default.
• W2111198130 countsByYear W21111981302013 @default.
• W2111198130 countsByYear W21111981302014 @default.
• W2111198130 countsByYear W21111981302015 @default.
• W2111198130 countsByYear W21111981302016 @default.
• W2111198130 countsByYear W21111981302017 @default.
• W2111198130 countsByYear W21111981302018 @default.
• W2111198130 countsByYear W21111981302019 @default.
• W2111198130 countsByYear W21111981302020 @default.
• W2111198130 countsByYear W21111981302021 @default.
• W2111198130 countsByYear W21111981302022 @default.
• W2111198130 countsByYear W21111981302023 @default.
• W2111198130 crossrefType "journal-article" @default.
• W2111198130 hasAuthorship W2111198130A5005763501 @default.
• W2111198130 hasConcept C10138342 @default.
• W2111198130 hasConcept C111472728 @default.
• W2111198130 hasConcept C126322002 @default.
• W2111198130 hasConcept C138885662 @default.
• W2111198130 hasConcept C142724271 @default.
• W2111198130 hasConcept C144133560 @default.
• W2111198130 hasConcept C17744445 @default.
• W2111198130 hasConcept C199539241 @default.
• W2111198130 hasConcept C204787440 @default.
• W2111198130 hasConcept C2777276634 @default.
• W2111198130 hasConcept C2777280699 @default.
• W2111198130 hasConcept C2779473830 @default.
• W2111198130 hasConcept C2779530757 @default.
• W2111198130 hasConcept C2779652045 @default.
• W2111198130 hasConcept C2988064887 @default.
• W2111198130 hasConcept C509550671 @default.
• W2111198130 hasConcept C512399662 @default.
• W2111198130 hasConcept C535046627 @default.
• W2111198130 hasConcept C71924100 @default.
• W2111198130 hasConcept C98274493 @default.
• W2111198130 hasConceptScore W2111198130C10138342 @default.
• W2111198130 hasConceptScore W2111198130C111472728 @default.
• W2111198130 hasConceptScore W2111198130C126322002 @default.
• W2111198130 hasConceptScore W2111198130C138885662 @default.
• W2111198130 hasConceptScore W2111198130C142724271 @default.
• W2111198130 hasConceptScore W2111198130C144133560 @default.
• W2111198130 hasConceptScore W2111198130C17744445 @default.
• W2111198130 hasConceptScore W2111198130C199539241 @default.
• W2111198130 hasConceptScore W2111198130C204787440 @default.
• W2111198130 hasConceptScore W2111198130C2777276634 @default.
• W2111198130 hasConceptScore W2111198130C2777280699 @default.
• W2111198130 hasConceptScore W2111198130C2779473830 @default.
• W2111198130 hasConceptScore W2111198130C2779530757 @default.
• W2111198130 hasConceptScore W2111198130C2779652045 @default.
• W2111198130 hasConceptScore W2111198130C2988064887 @default.
• W2111198130 hasConceptScore W2111198130C509550671 @default.

• next